Loading
AM
Actinogen Medical Limited Stock: price and insider trades · Australia
ISIN AU000000ACW3AU·
1 insider bought €10k of shares over the last 90 days, the latest by Unknown, filed 09 Sept 2026.
Actinogen Medical Limited: what insiders have been doing
Actinogen Medical Limited is a listed company. Its directors and officers file their transactions with ASX. The last twelve months, up to 18 October 2026, brought 8 filings signed by 5 insiders.
The flow runs one way only: 2 insiders bought (3 purchases totalling €10k) and nobody sold on the market. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The largest single trade was a purchase of €5,519, published on 9 September 2026. The buyers include 2 senior executives.
With 8 filings in twelve months, the company is more active than the median of 4 filings across the 1,605 companies we follow on the same exchange. Our records for Actinogen Medical Limited go back to 2026, with 3 purchases and no sales on the open market in total.
The latest purchase dates back some time: it was published 39 days ago, on 9 September 2026. Publication is fast: at least half of the trades appear on ASX on the same day. The shorter that gap, the sooner other investors can see what insiders have done.
Source: insider filings from ASX. Past trades are no guide to future returns.
Insider Decl.
8
Thresholds
n/a
Buy Volume
€10,127
3 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleUnknown2 buys
Dr Geoffrey Brooke1 buy
Since the insiders bought
- +40.6%Entry 0.03 · Close 16 Oct 2026 0.05
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 9 September 2026
Declarations8 total
0@ A$5,761.29551.0% of flowShareASXISIN AU000000ACW3ASX:2924-03128343-2A1693269
0@ A$10,324.91100.0% of flowShareASXISIN AU000000ACW3ASX:2924-03128341-2A1693268
0@ A$11,242.6949.0% of flowShareASXISIN AU000000ACW3ASX:2924-03123682-2A1690793
ShareASXASX:2924-03103918-2A1679401
1 shares@ A$0.050.0000% mcap100.0% of flowShareASXASX:2924-03103426-2A1679040
Canonical exit: 22 Sept 2026 (T+90)
0@ A$91,599.260.056% mcap100.0% of flowShareASXASX:2924-03089633-2A1671848
8 of 8 declarations
About Actinogen Medical Limited
Actinogen Medical Limited is a company focused on developing treatments for neurodegenerative diseases, particularly Alzheimer's disease. It is listed on the XASX market.
